Dear Friends and Colleagues,
It has been an honor and privilege to be the President of the World Allergy Organization (WAO) for the past two years. During this time, I was fortunate to see the great impact WAO makes throughout the world through involvement with the World Allergy Training Schools (WATS), participating as speakers in various scientific programs, and organizing meetings. >>Read More...
Inside the Issue
World Allergy Congress (WAC) 2018
2-5 March 2018
Orlando, Florida U.S.A.
Luo Zhang, MD, PhD
Professor, Department of Otolaryngology Head and Neck Surgery
Department of Allergy
Vice President, Beijing TongRen Hospital
Director, Beijing Institute of Otolaryngology
President, Chinese Society of Allergology
What inspired you to become more involved in the World Allergy Organization (WAO)?
China has the largest population in the world, with an increasing number of patients with allergic diseases. Chinese healthcare workers in the area need to learn the cutting edge knowledge of allergy. As a member of the WAO Board of Directors, I am able to connect WAO and its activities with the Chinese Society of Allergology.
What would you like to share about the work of your national member society?
In general, the prevalence of allergic disease is increasing with growing social burdens. As the president of the Chinese Society of Allergology, I am uniting doctors from different specialties to provide better healthcare to our patients.
What is one of your special interests in the field of allergy/immunology?
My work has focused on the pathophysiology of chronic rhinosinusitis; the regulation of airway ciliary activity; mechanisms of specific-allergen immunotherapy of allergic rhinitis; and surgical techniques of endoscopic sinus surgery.
Please provide any recent publications you would like to share.
Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: A multicenter study in Europe, Asia, and Oceania – Article Link
An increased prevalence of self-reported allergic rhinitis in major Chinese cities from 2005 to 2011 – Article Link
The World Allergy Organization is proud to announce the 2018-2019 WAO Board of Directors and Officers, who were recently ratified by the House of Delegates:
Ignacio Ansotegui (Spain) - President
Motohiro Ebisawa (Japan) - President-Elect
Francesca Levi-Schaffer (Israel) - Secretary-General
Luís Caraballo (Colombia) - Treasurer
Mario Sánchez Borges (Venezuela) - Past President
Lanny Rosenwasser (USA) - Historian
Mübeccel Akdis (Switzerland)
Zeinab Awad El-Sayed (Egypt)
Stanley Fineman (USA)
Paul Greenberger (USA)
Luciana Kase Tanno (Brazil/France)
Michael Levin (South Africa)
Bryan Martin (USA)
Mário Morais-Almeida (Portugal)
José Antonio Ortega-Martell (Mexico)
Giovanni Passalacqua (Italy)
Mimi Tang (Australia)
Gary Wong (Hong Kong)
Anahí Yáñez (Argentina)
Luo Zhang (China)
Psychological and lifestyle risk factors for asthma exacerbations and morbidity in children
Oland AA, Booster GD, Bender BG
Severe asthma and quality of life
Hossny E, Caraballo L, Casale T, El-Gamal Y, Rosenwasser L
Small airways disease in severe asthma
Carr T, Altisheh R, Zitt M
Acknowledgments: Thank you to the WAO Collaboration on Severe Asthma (COSA) for supporting the development of these papers. Thank you to Teva Pharmaceuticals, founding supporter, and Sanofi Genzyme Regeneron Pharmaceuticals, for supporting the distribution of the papers through independent educational grants.
Editors' Choice Literature Review
World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management
Activities and resources
New Education Resources
What's New in Severe Asthma Research
Tezepelumab in Adults with Uncontrolled Asthma
Proceedings of the 2017 WAO Symposium on Hot Topics in Allergy: Pediatric & Regulatory Aspects
Debates in Allergy Medicine: Allergy skin testing cannot be replaced by molecular diagnosis in the near future Read
Debates in Allergy Medicine: Molecular allergy diagnosis with ISAC will replace screenings by skin prick test in the future Read
Prevalence of papular urticaria caused by flea bites and associated factors in children 1-6 years of age in Bogotá, D.C. Read
Who has anaphylaxis in Brazil? Validation of a questionnaire for population studies Read
Otitis media with effusion and atopy: is there a causal relationship? Read
Psychological and lifestyle risk factors for asthma exacerbation and morbidity in children Read
Two case reports of desensitization in patients with hypersensitivity to iron Read
Checklist for a complete chronic urticaria medical history: an easy tool Read
The grass pollen season 2015: a proof of concept multi-approach study in three different European cities Read
A 17-year-old male with a Small Bowel Neuroendocrine Tumor: flushing differential diagnosis Read
The skin microbiome: impact of modern environments on skin ecology, barrier integrity, and systemic immune programming Read
World Allergy Organization Journal (WAO Journal) is the official journal of the World Allergy Organization (WAO), whose membership consists of 97 professional allergy, asthma and clinical immunology societies around the world. It is an open access, peer-reviewed global journal published by BioMed Central (BMC).
World Allergy Organization Journal publishes original research, clinical reviews, position papers, and epidemiological studies that contribute to current knowledge in patient care. The new Debates in Allergy Medicine series contributes the hottest current topics in allergy. The Journal aims to publish works with specific clinical relevance and practical measures that are critical for the practice of allergy anywhere in the world, to highlight the global impact of the allergy burden. The Journal provides a vehicle to highlight newer approaches for the evaluation of disease outcomes and concerning treatments and interventions.
World Allergy Organization Journal is interested in reviews and original research papers on:
Drug allergy in the era of biologics
Omic sciences in allergy
Ethics of publication in allergy
All articles published by World Allergy Organization Journal are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers at https://waojournal.biomedcentral.com/articles.
Other benefits of publishing in World Allergy Organization Journal include:
- International exposure
- Rapid publication
- Blinded peer review process
- Open access
All articles published in World Allergy Organization Journal are included in: CAS, DOAJ, Embase, Emerging Sources Citation Index, PubMed, PubMed Central, SCImago, and Scopus.
The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation.
Send your manuscript to the editors at email@example.com or submit online at https://www.editorialmanager.com/waoj/default.aspx.
For more information, visit the journal website http://www.waojournal.org.
Submission guidelines are available at: https://waojournal.biomedcentral.com/submission-guidelines.
Alessandro Fiocchi, MD and Erika Jensen-Jarolim, MD